Results 61 to 70 of about 254,671 (299)
Tuberculosis due to Mycobacterium bovis and Mycobacterium caprae in sheep [PDF]
Tuberculosis was diagnosed in three flocks of sheep in Galicia, Spain, in 2009 and 2010. Two flocks were infected with Mycobacterium bovis and one flock was infected with Mycobacterium caprae. Infection was confirmed by the comparative intradermal tuberculin test, bacteriology, molecular analysis and histopathology. Sheep have the potential to act as a
Antón Ocampo +9 more
openaire +4 more sources
Background Mycobacterium bovis is known to have a wide host range and has been isolated from numerous free-ranging wildlife species, carnivores included. In bears, M. bovis has been previously reported only from a culture of pooled lymph nodes of a black
Rosario Fico +6 more
doaj +1 more source
Mycobacterium bovis infection was first described in free-ranging wildlife in France in 2001, with subsequent detection in hunter-harvested ungulates and badgers in areas where outbreaks of bovine tuberculosis (TB) were also detected in cattle ...
Édouard Réveillaud +12 more
semanticscholar +1 more source
The ability to DNA fingerprint Mycobacterium bovis isolates helped to define the role of wildlife in the persistence of bovine tuberculosis in New Zealand.
M. Price-Carter +17 more
semanticscholar +1 more source
Mycobacterium bovis é membro do complexo Mycobacterium tuberculosis (MTBC), grupo este composto por espécies com grande homologia genética. É o agente etiológico da tuberculose bovina, importante zoonose transmissível ao homem, principalmente através da ...
Eduardo Eustáquio de Souza Figueiredo +4 more
doaj +1 more source
Mycobacterium microti Infection in Red Foxes in France
Mycobacterium microti, member of the Mycobacterium tuberculosis, complex is known to interfere in the screening and diagnosis of bovine tuberculosis.
Lorraine Michelet +5 more
doaj +1 more source
Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges. [PDF]
Introduction: Tuberculosis (TB) remains a major health threat and it is now clear that the current vaccine, BCG, is unable to arrest the global TB epidemic. A new vaccine is needed to either replace or boost BCG so that a better level of protection could
Barclay WR +8 more
core +1 more source
This study demonstrates that cholesterol in messenger RNA‐lipid nanoparticles (mRNA‐LNPs) can be completely replaced with an immunopotentiating lipid, i.e., a synthetic analogue of the C‐type lectin receptor agonist monomycoloyl glycerol (MMG‐1), without compromising physicochemical properties, in vivo transfection efficiency, and immunogenicity of the
Abhijeet G. Lokras +19 more
wiley +1 more source
Pulmonary Tuberculosis andMycobacterium bovis,Uganda [PDF]
To the Editor: In 2005, prevalence of human tuberculosis (TB) in Uganda was 559 cases/100,000 population (1). In 2002, the average number of extrapulmonary TB cases in humans, considered a crude indicator of the level of bovine TB, was 7.5% of TB cases for Uganda and 6% for Mbarara district, the main Ugandan milk basin (2). Worldwide, the proportion of
Byarugaba, Frederick +3 more
openaire +4 more sources
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source

